Journal articleInfect Dis Poverty · May 15, 2020
BACKGROUND: With the second largest tuberculosis (TB) burden globally, China is committed to actively engage in international TB clinical trials to contribute to global TB research. However, lack of research capacity among local sites has been identified a ...
Full textLink to itemCite
Journal articleTrop Med Int Health · September 2019
OBJECTIVE: Poor compliance with existing guidelines for tuberculosis (TB) care and treatment is an issue of concern in China. We assessed health service use by TB patients over the entire treatment process and compared it to the recommended guidelines. MET ...
Full textLink to itemCite
Journal articleJ Int AIDS Soc · October 2018
INTRODUCTION: Inadequate community and stakeholder engagement can lead to accusations that research is unethical and can delay or slow research or translation of results to practice. Such experiences have led major funders as well as regulatory and advisor ...
Full textLink to itemCite
Journal articleMMWR Morb Mortal Wkly Rep · June 2, 2017
Monitoring prevalence of advanced human immunodeficiency virus (HIV) disease (i.e., CD4+ T-cell count <200 cells/μL) among persons starting antiretroviral therapy (ART) is important to understand ART program outcomes, inform HIV prevention strategy, and fo ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · March 1, 2017
SETTING: A post-hoc exploratory analysis of a randomized, open-label clinical trial that enrolled 8053 participants from the United States, Canada, Brazil, and Spain. OBJECTIVE: To assess factors associated with non-completion of study follow-up (NCF) in a ...
Full textLink to itemCite
Journal articleJ Empir Res Hum Res Ethics · July 2016
Good Participatory Practice Guidelines for TB Drug Trials (GPP-TB) were issued in 2012, based on similar guidelines for HIV prevention and reflecting growing acceptance of the importance of community engagement and participatory strategies in clinical rese ...
Full textLink to itemCite
Journal articleCrit Care Med · June 2016
OBJECTIVE: To determine the impact of adjuvant corticosteroids administered to patients hospitalized with influenza A (H7N9) viral pneumonia. DESIGN: The effects of adjuvant corticosteroids on mortality were assessed using multivariate Cox regression and a ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · June 2016
BACKGROUND: Shorter treatment regimens for tuberculosis (TB) are deemed vital for advancing TB control. Murine studies have suggested potential new regimens; however, Phase II human studies of these drug combinations have not shown clear improvement in 2-m ...
Full textLink to itemCite
Journal articleMMWR Morb Mortal Wkly Rep · November 27, 2015
Equitable access to antiretroviral therapy (ART) for men and women with human immunodeficiency virus (HIV) infection is a principle endorsed by most countries and funding bodies, including the U.S. President's Emergency Plan for AIDS (acquired immunodefici ...
Full textLink to itemCite
Journal articleClin Infect Dis · October 15, 2015
Progress in tuberculosis clinical research is hampered by a lack of reliable biomarkers that predict progression from latent to active tuberculosis, and subsequent cure, relapse, or failure. Regional Prospective Observational Research in Tuberculosis (RePO ...
Full textLink to itemCite
Journal articleClin Infect Dis · August 15, 2015
BACKGROUND: Weekly rifapentine plus isoniazid for 3 months (3HP) is as effective as daily isoniazid for 9 months (9H) for latent tuberculosis infection in high-risk persons, but there have been reports of possible flu-like syndrome. METHODS: We identified ...
Full textLink to itemCite
Journal articlePublic Health Action · June 21, 2015
Case notification rates of tuberculosis (TB) in Bangladesh remain poor despite a high burden of disease. Peer sputum collection among underserved populations was implemented to expand case notification and to provide socially empowering roles in society fo ...
Full textLink to itemCite
Journal articleMMWR Morb Mortal Wkly Rep · November 28, 2014
Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to declines of about 30% in the global annual number of human immunodeficiency (HIV)-related deaths and declines in global HIV incidence, estimated annual HIV-related deaths among ...
Link to itemCite
Journal articleInt J Tuberc Lung Dis · May 2014
SETTING: Twenty tuberculosis (TB) clinics in the United States and Canada. OBJECTIVE: To evaluate the efficacy and safety of a 6-month intermittent regimen of rifampin (RMP), pyrazinamide (PZA) and ethambutol (EMB) in human immunodeficiency virus (HIV) neg ...
Full textLink to itemCite
Journal articleBMC Infect Dis · February 20, 2014
BACKGROUND: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textOpen AccessLink to itemCite
Journal articleBMC Infectious Diseases · February 20, 2014
Background: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textCite
Journal articleMMWR Morb Mortal Wkly Rep · November 29, 2013
Evaluation of differences between human immunodeficiency virus (HIV)-infected men and women in antiretroviral therapy (ART) enrollment characteristics and outcomes might identify opportunities to improve ART program patient outcomes and prevention impact. ...
Link to itemCite
Journal articleClin Infect Dis · August 2012
Treatment of drug-resistant tuberculosis is hindered by the high toxicity and poor efficacy of second-line drugs. New compounds must be used together with existing drugs, yet clinical trials to optimize combinations of drugs for drug-resistant tuberculosis ...
Full textLink to itemCite
Journal articleJ Infect Dis · May 15, 2012
The development, evaluation, and implementation of new and improved diagnostics have been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis researchers and clinicians alike. These needs exist in international and domestic ...
Full textLink to itemCite
Journal articlePLoS One · 2012
BACKGROUND: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment of latent multiple-drug resi ...
Full textOpen AccessLink to itemCite
Journal articlePLoS One · 2012
The monocyte chemotactic protein-1 (MCP-1) is a chemokine that plays an important role in the recruitment of monocytes to M. tuberculosis infection sites, and previous studies have reported that genetic variants in MCP1 are associated with differential sus ...
Full textLink to itemCite
Journal articleN Engl J Med · December 8, 2011
BACKGROUND: Treatment of latent Mycobacterium tuberculosis infection is an essential component of tuberculosis control and elimination. The current standard regimen of isoniazid for 9 months is efficacious but is limited by toxicity and low rates of treatm ...
Full textLink to itemCite
Journal articleAcad Med · March 2011
Persons with limited English proficiency (LEP) constitute a growing portion of the U.S. population, yet they are underrepresented in clinical research. This inherently limits the societal benefits of the research and its generalizability to ethnic populati ...
Full textLink to itemCite
Journal articlePLoS One · February 9, 2011
We examined whether polymorphisms in interleukin-12B (IL12B) associate with susceptibility to pulmonary tuberculosis (PTB) in two West African populations (from The Gambia and Guinea-Bissau) and in two independent populations from North and South America. ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · February 2011
SETTING: North Carolina, United States. OBJECTIVE: To investigate the demographic and behavioral risk factors associated with death among tuberculosis (TB) patients in North Carolina. DESIGN: Retrospective cohort of all TB patients reported in North Caroli ...
Link to itemCite
Journal articlePLoS One · 2011
RATIONALE: Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. OBJECTIVES: To inform clinical tr ...
Full textOpen AccessLink to itemCite
Journal articleAcad Radiol · February 2010
RATIONALE AND OBJECTIVES: Chest radiographic findings are important for diagnosis and management of tuberculosis. The reliability of these findings is therefore of interest. We sought to describe interobserver reliability of chest radiographic findings in ...
Full textLink to itemCite
Journal articleHum Genet · January 2010
Tuberculosis (TB) is a global public health problem and a source of preventable deaths each year, with 8.8 million new cases of TB and 1.6 million deaths worldwide in 2005. Approximately, 10% of infected individuals develop pulmonary or extrapulmonary TB, ...
Full textLink to itemCite
Journal articleInternational Journal of Functional Informatics and Personalised Medicine · January 1, 2010
We report the development and implementation of a methodology for standardising clinical data elements. The methodology, piloted using Tuberculosis (TB) and Acute Coronary Syndromes (ACS) domains, relies on clinicians for natural language definitions and o ...
Full textCite
Journal articleHum Genet · November 2009
Tuberculosis (TB) has substantial mortality worldwide with 5-10% of those exposed progressing to active TB disease. Studies in mice and humans indicate that the inducible nitric oxide synthase (iNOS) molecule plays an important role in immune response to T ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · October 2009
SETTING: A community-based voluntary counseling and testing (VCT) center in Moshi, Tanzania. OBJECTIVE: To compare rates of prior human immunodeficiency virus (HIV) testing among clients with and without previous tuberculosis (TB) treatment, and HIV seropo ...
Link to itemCite
Journal articleAIDS Patient Care STDS · October 2009
Persons coinfected with tuberculosis (TB) and HIV are at high risk of death, in part due to suboptimal utilization of HIV-specific health care. We sought to better understand HIV-associated health care utilization and mortality in a retrospective cohort of ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · September 2009
SETTING: Host defense factors may influence the development of active tuberculosis (TB). OBJECTIVE: To test variants in solute carrier family 11A, member 1 (SLC11A1), for an association with TB. METHODS: A mixed case-control study of TB cases, relatives or ...
Link to itemCite
Journal articleAm J Respir Crit Care Med · August 1, 2009
RATIONALE: Moxifloxacin has potent activity against Mycobacterium tuberculosis in vitro and in a mouse model of antituberculosis (TB) chemotherapy, but data regarding its activity in humans are limited. OBJECTIVES: Our objective was to compare the antimicr ...
Full textLink to itemCite
Journal articleAm J Respir Crit Care Med · June 1, 2009
RATIONALE: Isoniazid given daily for 9 months is the standard treatment for latent tuberculosis infection (LTBI), but its effectiveness is limited by poor completion rates. Shorter course regimens and regimens using directly observed therapy result in impr ...
Full textLink to itemCite
Journal articlePharmacotherapy · May 2009
STUDY OBJECTIVE: To determine the feasibility of therapeutic drug monitoring for adjusting low serum antimycobacterial concentrations in patients with both tuberculosis and advanced human immunodeficiency virus (HIV). DESIGN: Retrospective cohort study. DA ...
Full textLink to itemCite
Journal articleJ Infect · May 2009
OBJECTIVES: Excess alcohol use represents a significant challenge in tuberculosis control. Whether alcohol use enhances transmission of Mycobacterium tuberculosis is not known. METHODS: We analyzed North Carolina, USA surveillance data for all adult (>14 y ...
Full textLink to itemCite
Journal articleJ Infect · November 2008
OBJECTIVES: Excess alcohol use represents a significant challenge in tuberculosis control. Whether alcohol use enhances transmission of Mycobacterium tuberculosis is not known. METHODS: We analyzed North Carolina, USA surveillance data for all adult (> 14 ...
Full textLink to itemCite
Journal articleInt J Tuberc Lung Dis · September 2008
SETTING: Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear. OBJE ...
Link to itemCite
Journal articleJ Clin Microbiol · August 2008
Organisms within the Mycobacterium avium complex (MAC) may have differential virulence. We compared 33 subjects with MAC pulmonary disease to 75 subjects with a single positive culture without disease. M. avium isolates were significantly more likely to be ...
Full textLink to itemCite
Journal articleBMC Public Health · April 4, 2008
BACKGROUND: The proportion of extrapulmonary tuberculosis (EPTB) reported in the United States has been gradually increasing. HIV infection and foreign birth are increasingly associated with tuberculosis and understanding their effect on the clinical prese ...
Full textOpen AccessLink to itemCite
Journal articleClin Infect Dis · August 1, 2007
Tuberculosis (TB) is an enormous global public health problem. Cases of extensively drug-resistant TB (XDR-TB) are being reported in increasing numbers across the globe. A large outbreak of XDR-TB associated with rapid and nearly universal mortality has be ...
Full textLink to itemCite
Journal articleArch Intern Med · March 26, 2007
BACKGROUND: Interleukin 2 (IL-2) administration increases CD4 counts in persons with higher counts. This study investigated persons with moderately advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy (HAART). METH ...
Full textLink to itemCite
Journal articleDrug Information Journal · January 1, 2007
Interactions between the health care and clinical research communities are currently inefficient. The present environment forces unnecessary redundancy, from the capture of patient data in the clinician-patient encounter to multiple uses of that data. Clin ...
Full textCite
Journal articleInt J Tuberc Lung Dis · July 2006
Featured Publication
SETTING: North Carolina, USA. OBJECTIVE: To understand physicians' knowledge and attitudes toward the treatment of young children with latent tuberculosis infection (LTBI) in a low-incidence region. DESIGN: Cross-sectional survey of 525 pediatricians and 5 ...
Link to itemCite
Journal articleArch Pediatr Adolesc Med · June 2006
Featured Publication
OBJECTIVES: To investigate an increase in active pediatric tuberculosis (TB) cases in North Carolina from 9 cases in 2001 to 32 cases in 2002, and to pilot test a screening tool for detection of latent TB infection in children. DESIGN: Retrospective cohort ...
Full textLink to itemCite
Journal articleInt J Infect Dis · November 2005
Featured Publication
Despite attempts to standardize tuberculosis (TB) control strategies, there remains wide variation in the selection and implementation of control strategies within and among nations. Some of this variation is appropriate; based on wide variations in the av ...
Full textLink to itemCite
Journal articleProc Am Thorac Soc · 2005
Featured Publication
Collagen-vascular diseases are associated with immune dysregulation and inflammation, leading to tissue destruction or compromise. Immunosuppression is more commonly associated with the drugs used to treat these disorders than with the diseases themselves. ...
Full textLink to itemCite
Journal articleCurr Opin Rheumatol · July 2004
Featured Publication
PURPOSE OF REVIEW: There are three tumor necrosis factor-alpha inhibitors on the US and European markets today, and uncommon but devastating infectious complications accompany their use. This review describes the most important pathogen-specific infections ...
Full textLink to itemCite
Journal articleClinics in Family Practice · January 1, 2004
Family physicians can make a significant impact on the sexual health of adolescents and on their adult lives by increasing the access of teens to health care and then addressing their sexual health needs. Preventive immunizations, direct patient education, ...
Full textCite
Journal articleAm J Respir Crit Care Med · March 15, 2003
Featured Publication
An alternative regimen for the treatment of latent tuberculosis infection is 2 months of rifampin and pyrazinamide, but some patients have died of hepatitis associated with this therapy. One hundred fourteen patients received rifampin/pyrazinamide in Wake ...
Full textLink to itemCite
Journal articleJ Antimicrob Chemother · February 2003
To determine the effect of omeprazole on peak serum concentrations (C(max)) of itraconazole oral solution (IOS), we carried out a randomized, open-label, prospective, crossover study. Fifteen healthy, non-pregnant adults received a single dose of IOS 400 m ...
Full textLink to itemCite
Journal articleAm Fam Physician · January 15, 2003
Chronic illness and its treatments can have a negative impact on sexual functioning. The mechanism of interference may be neurologic, vascular, endocrinologic, musculoskeletal, or psychologic. Patients may mistakenly perceive a medical prohibition to the r ...
Link to itemCite
Journal articleAm Fam Physician · November 1, 2002
Family physicians must proactively address the sexual health of their patients. Effective sexual health care should address wellness considerations in addition to infections, contraception, and sexual dysfunction. However, physicians consistently underesti ...
Link to itemCite
Journal articleClin Infect Dis · August 15, 2002
Featured Publication
We report a case of retinal toxoplasmosis that occurred in a patient with acquired immunodeficiency syndrome who had a previous diagnosis of cerebral toxoplasmosis, despite the patient having had a robust immune response to highly active antiretroviral the ...
Full textLink to itemCite
Journal articleAm J Respir Crit Care Med · June 1, 2002
Featured Publication
Once-weekly rifapentine 600 mg plus isoniazid (INH) during the continuation phase treatment of tuberculosis is associated with a relapse rate higher than that of twice-weekly rifampin plus INH. The safety and tolerability of higher rifapentine doses need t ...
Full textLink to itemCite
Journal articleSouth Med J · February 2002
Featured Publication
BACKGROUND: Human immunodeficiency virus (HIV) testing is recommended for all patients with tuberculosis (TB). METHODS: Surveillance data for all reported cases of TB in North Carolina from 1993 to 1999 were examined to assess HIV testing practices. RESULT ...
Link to itemCite
Journal articleInfect Control Hosp Epidemiol · November 2001
Featured Publication
We prospectively assessed the management of patients with suspected tuberculosis (TB) in an area with a high prevalence of nontuberculous mycobacteria (NTM) and a low incidence of TB. Clinicians' assessments were sensitive for TB but had poor predictive va ...
Full textLink to itemCite
Journal articleClin Infect Dis · August 15, 2001
We describe a 27-year-old woman with peritonitis due to Mycobacterium bovis that initially appeared to be ovarian cancer. Clinicians should include this disease in the differential diagnosis of ovarian cancer and should consider laparoscopic diagnosis in t ...
Full textLink to itemCite
Journal articleJ Infect Dis · July 15, 2001
Featured Publication
Many human immunodeficiency virus (HIV)-infected persons receive prolonged treatment with DNA-reactive antiretroviral drugs. A prospective study was conducted of 26 HIV-infected men who provided samples before treatment and at multiple times after beginnin ...
Full textLink to itemCite
Journal articleJ Infect Dis · June 1, 2001
Featured Publication
To confirm the vertical transmission of multidrug-resistant (MDR) human immunodeficiency virus type 1 (HIV-1) and to assess its impact on further evolution of drug-resistant virus in an infant, proviral DNA amplified from infected peripheral blood mononucl ...
Full textLink to itemCite
Journal articleObstet Gynecol · November 2000
Featured Publication
OBJECTIVE: To compare health outcomes and costs of different strategies for treatment of latent tuberculosis infection in pregnancy. METHODS: Using a Markov decision-analysis model, the following three strategies were evaluated for treatment of latent tube ...
Full textLink to itemCite
Journal articleInfect Control Hosp Epidemiol · January 2000
Featured Publication
The project goal was to decrease excessive vancomycin use. Interventions included an educational chart note the first day of therapy, followed by pharmacists discussing the need for continued therapy with patients' physicians. Empirical vancomycin use impr ...
Full textLink to itemCite
Journal articleAm J Med · August 1999
PURPOSE: Weight loss is a strong predictor of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. Men with acquired immunodeficiency syndrome (AIDS) lose body cell mass. Hypogonadism is also common. This study tested the effica ...
Full textLink to itemCite
Journal articleCurr Infect Dis Rep · April 1999
The resurgence in cases of active tuberculosis in North America in the past decade has prompted increases in funding for tuberculosis treatment, research, and education. As a result, the number of new cases of tuberculosis has declined and cases occur in s ...
Full textLink to itemCite
Journal articleInfection · 1998
The first reported case of Clostridium septicum myonecrosis in an adult with aplastic anemia is described. The patient presented with sepsis, a parapharyngeal abscess that necessitated emergent intubation, and severe intravascular hemolysis attributed to c ...
Full textLink to itemCite
Journal articleClinical Infectious Diseases · December 1, 1997
Lipid-based antifungal products have been developed, and some may reduce nephrotoxicily and infusion-related side-effects, compared to standard amphotericin B (AmB). However, questions remain about optimal daily and cumulative dosing strategies, and no pub ...
Cite
Journal articleClinical Infectious Diseases · December 1, 1997
Vancomycin (vanc) is the only licensed antibiotic effective against several highly resistant bacteria. Unfortunately, its use has contributed to the emergence of vancomycin-resistant enterococci (VRE). The first VRE was isolated at Duke in 1992; by 1995, 1 ...
Cite
Journal articleN C Med J · 1997
In summary, each person must be responsible for his or her own sexual health and, unfortunately, there are some deadly infections in the population these days. We hope this frank discussion of options will help you make smart decisions about your sex life. ...
Link to itemCite
Journal articleAIDS Res Hum Retroviruses · June 10, 1996
The HIV-1 genome encodes a protease that is required for viral processing of the precursor polyproteins Pr55gag and Pr160gag-pol. Interference with this process in human lymphocytes inhibits production of infectious virus. We tested the ability of several ...
Full textLink to itemCite
Journal articleJ Mol Cell Cardiol · October 1995
Patients with diabetes mellitus that exhibit cardiac pump failure display compromised stroke volume, ejection fraction, and slower rates of rise and fall of left ventricular (LV) dP/dt in the absence of ischemic injury. We hypothesized that diabetic cardio ...
Full textLink to itemCite
Journal articleJ Virol · July 1995
CD4 is the predominant cell membrane protein that binds human immunodeficiency virus type 1 (HIV-1) gp120 and facilitates HIV-1 infection, but other membrane-associated molecules may be involved in determining HIV-1 cellular infection. Our prior work had s ...
Full textLink to itemCite
Journal articleAm J Hosp Palliat Care · 1995
Hospice care for patients with AIDS often differs from care provided to patients with other terminal illnesses, such as cancer. We designed a seminar series to educate regional hospice staff about these differences and subsequently determined if the educat ...
Full textLink to itemCite
Journal articleTuber Lung Dis · December 1994
SETTING: Large academic medical center in Tanzania. OBJECTIVES: To determine the etiologies and outcomes of large pericardial effusions in HIV-infected and uninfected patients. DESIGN: Prospective cohort study of patients admitted with new large pericardia ...
Full textLink to itemCite
Journal articleJ Leukoc Biol · November 1994
Neopterin is a pteridine produced by human mononuclear phagocytes, usually in response to interferon-gamma (IFN-gamma) stimulation. Increasing serum levels of neopterin correlate with clinical progression to AIDS in HIV-infected people, but the factors tha ...
Full textLink to itemCite
Journal articleVaccine · September 1993
Patients undergoing chronic haemodialysis are at increased risk for infection with hepatitis B virus (HBV), but response to currently available vaccines is suboptimal. We undertook a 4-year prospective study of the efficacy of hepatitis B vaccine in patien ...
Full textLink to itemCite
Journal articleJ Infect Dis · August 1993
Human immunodeficiency virus type 1 (HIV-1) infects mononuclear phagocytes, cells that may serve as a reservoir for viral persistence. Infection with HIV-1 leads to progressive compromise of the immune system, resulting in infections with opportunistic pat ...
Full textLink to itemCite
Journal articleAIDS · February 1993
OBJECTIVE: To determine whether specific intestinal parasites are associated with HIV infection in Tanzanian children with chronic diarrhea. DESIGN: A prospective, cross-sectional study. SETTING: Muhimbili University College of Health Sciences, Dar es Sala ...
Full textLink to itemCite
Journal articleTrop Geogr Med · October 1992
Concurrent infection with HIV-1 and Mycobacterium tuberculosis is increasingly common in East Africa. In the past, a drug regimen consisting of 2 months of intramuscular streptomycin plus 12 months of isoniazid and thiacetazone has been used in tuberculosi ...
Link to itemCite
Journal articleContraception · January 1987
Women using estrogen-progestin oral contraceptive agents have a marked decrease in the activity of hepatic triglyceride lipase, an enzyme believed to be involved in the catabolism of lipoprotein remnants. The hypothesis that women receiving these agents ha ...
Full textLink to itemCite